Professor of Pharmaceutical Engineering, Graz University of Technology, and CEO of RCPE
Khinast has hundreds of publications in peer-reviewed journals and a number of patents registered under his name. He has worked with numerous pharmaceutical companies as an advisor for the implementation of novel drug formulations.
“Pharma will look back on COVID-19 as a game-changer that hopefully brought back API production to Europe. We will be better prepared to face another health crisis in the future by reacting faster and making rapidly invented drugs accessible for a large number of people around the world.”